收费全文 | 3771篇 |
免费 | 360篇 |
国内免费 | 19篇 |
耳鼻咽喉 | 65篇 |
儿科学 | 95篇 |
妇产科学 | 47篇 |
基础医学 | 324篇 |
口腔科学 | 132篇 |
临床医学 | 351篇 |
内科学 | 843篇 |
皮肤病学 | 166篇 |
神经病学 | 312篇 |
特种医学 | 191篇 |
外科学 | 712篇 |
综合类 | 104篇 |
现状与发展 | 30篇 |
预防医学 | 225篇 |
眼科学 | 113篇 |
药学 | 210篇 |
中国医学 | 11篇 |
肿瘤学 | 219篇 |
2024年 | 15篇 |
2023年 | 186篇 |
2022年 | 41篇 |
2021年 | 80篇 |
2020年 | 97篇 |
2019年 | 99篇 |
2018年 | 129篇 |
2017年 | 110篇 |
2016年 | 102篇 |
2015年 | 113篇 |
2014年 | 181篇 |
2013年 | 174篇 |
2012年 | 157篇 |
2011年 | 183篇 |
2010年 | 190篇 |
2009年 | 167篇 |
2008年 | 182篇 |
2007年 | 179篇 |
2006年 | 155篇 |
2005年 | 143篇 |
2004年 | 135篇 |
2003年 | 141篇 |
2002年 | 108篇 |
2001年 | 72篇 |
2000年 | 112篇 |
1999年 | 102篇 |
1998年 | 45篇 |
1997年 | 64篇 |
1996年 | 47篇 |
1995年 | 44篇 |
1994年 | 44篇 |
1993年 | 43篇 |
1992年 | 36篇 |
1991年 | 37篇 |
1990年 | 38篇 |
1989年 | 47篇 |
1988年 | 53篇 |
1987年 | 33篇 |
1986年 | 24篇 |
1985年 | 39篇 |
1984年 | 22篇 |
1983年 | 16篇 |
1982年 | 11篇 |
1981年 | 14篇 |
1980年 | 14篇 |
1979年 | 11篇 |
1978年 | 13篇 |
1977年 | 16篇 |
1976年 | 18篇 |
1975年 | 16篇 |
Background
Chronic kidney disease (CKD) is highly prevalent in patients with diabetes or hypertension in primary care. A shared care model could improve quality of care in these patientsAim
To assess the effect of a shared care model in managing patients with CKD who also have diabetes or hypertension.Design and setting
A cluster randomised controlled trial in nine general practices in The Netherlands.Method
Five practices were allocated to the shared care model and four practices to usual care for 1 year. Primary outcome was the achievement of blood pressure targets (130/80 mmHg) and lowering of blood pressure in patients with diabetes mellitus or hypertension and an estimated glomerular filtration rate (eGFR)<60ml/min/1.73m2.Results
Data of 90 intervention and 74 control patients could be analysed. Blood pressure in the intervention group decreased with 8.1 (95% CI = 4.8 to 11.3)/1.1 (95% CI = −1.0 to 3.2) compared to −0.2 (95% CI = −3.8 to 3.3)/−0.5 (95% CI = −2.9 to 1.8) in the control group. Use of lipid-lowering drugs, angiotensin-system inhibitors and vitamin D was higher in the intervention group than in the control group (73% versus 51%, 81% versus 64%, and 15% versus 1%, respectively, [P = 0.004, P = 0.01, and P = 0.002]).Conclusion
A shared care model between GP, nurse practitioner and nephrologist is beneficial in reducing systolic blood pressure in patients with CKD in primary care. 相似文献Expression of the phosphatase of regenerating liver-3 (PRL-3) is known to promote tumor growth in gastrointestinal adenocarcinomas, and the incidence of tumor formation upon inflammatory events correlates with PRL-3 levels in mouse models. These carcinomas and their onset are associated with the impairment of intestinal cell homeostasis, which is regulated by a balanced number of Paneth cells and Lgr5 expressing intestinal stem cells (Lgr5+ ISCs). Nevertheless, the consequences of PRL-3 overexpression on cellular homeostasis and ISC fitness in vivo are unexplored. Here, we employ a doxycycline-inducible PRL-3 mouse strain to show that aberrant PRL-3 expression within a non-cancerous background leads to the death of Lgr5+ ISCs and to Paneth cell expansion. A higher dose of PRL-3, resulting from homozygous expression, led to mice dying early. A primary 3D intestinal culture model obtained from these mice confirmed the loss of Lgr5+ ISCs upon PRL-3 expression. The impaired intestinal organoid formation was rescued by a PRL inhibitor, providing a functional link to the observed phenotypes. These results demonstrate that elevated PRL-3 phosphatase activity in healthy intestinal epithelium impairs intestinal cell homeostasis, which correlates this cellular mechanism of tumor onset with PRL-3-mediated higher susceptibility to tumor formation upon inflammatory or mutational events.
Key messages
? Transgenic mice homozygous for PRL-3 overexpression die early.
? PRL-3 heterozygous mice display disrupted intestinal self-renewal capacity.
? PRL-3 overexpression alone does not induce tumorigenesis in the mouse intestine.
? PRL-3 activity leads to the death of Lgr5+ ISCs and Paneth cell expansion.
? Impairment of cell homeostasis correlates PRL-3 action with tumor onset mechanisms.
相似文献